| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |